Measuring Impact in Patient-Centered Drug Development Conference

戻る Agenda

Session 8: Implementing Metrics - Where are We Going?

Session Chair(s)

Suzanne Schrandt, JD

Founder, Chief Executive Office and Chief Patient Advocate

ExPPect, United States

Measuring the impact of patient engagement efforts is a tool for ensuring meaningful exchange and for driving toward meaningful outcomes. This session presents a frank and forward looking discussion about addressing the constraints around utilizing patient engagement metrics and new initiatives that will help to advance the field.

Learning Objective : At the conclusion of this session, participants should be able to:
Identify challenges and constraints around measuring the impact of patient engagement
Describe approaches to addressing these challenges and constraints
Discuss the impact of key initiatives on the use of appropriate metrics to advance patient engagement

Speaker(s)

Patient-Centricity & Ethics in Pharma

Jennifer Miller, PhD

Yale School of Medicine, United States

Associate Professor of Medicine; Co-Director, Program for Biomedical Ethics

Implementing Metrics - Where are We Going?

Theresa Mullin, PhD

FDA, United States

Associate Center Director - Strategic Initiatives, CDER